Product Information
CITALOPRAM HBR 40 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0423 per EA under NDC 69097082407. Its NADAC has been published 516 times since Aug 10, 2016.
Strength
40 mg/1
Manufacturer
Cipla USA Inc.NDC
69097082407
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CITALOPRAM HYDROBROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077534On Market Since
7/22/2016
Pharmacological Classes
Price Statistics
The NADAC for CITALOPRAM HBR 40 MG TABLET has been published 516 times since Aug 10, 2016, and over the history we have for it it has risen 5.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0423 per EA |
|---|---|
| All-time high | $0.0465 (Nov 13, 2024) |
| All-time low | $0.0347 (Oct 23, 2019) |
| 52-week high | $0.0464 |
| 52-week low | $0.0423 |
| Median price | $0.0394 |
| Average price | $0.0402 |
| Largest weekly change | -23.6% (Nov 20, 2024) |
| Weeks tracked | 516 |
| Tracking since | Aug 10, 2016 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CITALOPRAM HBR 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CITALOPRAM HBR 40 MG TABLET, manufactured by Cipla USA Inc., is $0.0423 per EA (NDC 69097082407), effective Jun 24, 2026.
How has the price of CITALOPRAM HBR 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for CITALOPRAM HBR 40 MG TABLET has risen 5.5%. It has been tracked across 516 weekly CMS publications since Aug 10, 2016.
What are the highest and lowest recorded NADAC prices for CITALOPRAM HBR 40 MG TABLET?
Since Aug 10, 2016, the NADAC for CITALOPRAM HBR 40 MG TABLET has ranged from a low of $0.0347 (Oct 23, 2019) to a high of $0.0465 (Nov 13, 2024), with a median of $0.0394 per EA.
Are there cheaper alternatives to CITALOPRAM HBR 40 MG TABLET?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, CITALOPRAM HBR 40 MG TABLET, is $0.0355 per EA — about 16% below CITALOPRAM HBR 40 MG TABLET.
Who manufactures CITALOPRAM HBR 40 MG TABLET?
CITALOPRAM HBR 40 MG TABLET (NDC 69097082407) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification